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The effects of islet-activating protein (IAP), a Bordetella pertussis toxin, on insulin- and isoprenaline- 
stimulated glucose transport were studied in isolated rat adipocytes. Basal as well as insulin-stimulated 
glucose transport were not affected when cells were pretreated with IAP. In contrast, IAP pretreatment 
abolished the stimulatory effect of isoprenaline. When IAP-pretreated cells were exposed to a combination 
of insulin and isoprenaline, the catecholamine significantly reduced the stimulatory effect of insulin. Since 
IAP is supposed to specifically block the inhibitory component Nr of adenylate cyclase, the results uggest 
that: (a) the effect of insulin is unrelated to the regulation of adenylate cyclase; (b) isoprenaline may exert 
both stimulatory and inhibitory effects depending on activation of Nr. The inhibitory regulation of 
adenylate cyclase may thus be a pivotal ink in the regulation of glucose transport. 
Insulin Isoprenaline Rat adipocyte Islet-activating protein 
1. INTRODUCTION 
Glucose transport across the cell membrane is 
one of the rate limiting steps of glucose 
metabolism in the fat cell controlled by insulin [ 11. 
The stimulatory action of insulin may be 
modulated, although probably not mediated as 
was initially proposed, by cellular cyclic AMP 
levels [2,3]. Recently, attention has been focused 
on the insulin antagonist action of catecholamines 
in the fat cell at the receptor and at the postrecep- 
tor level. Two groups reported that insulin recep- 
tor binding was decreased by catecholamines in 
parallel to a reduction of the response of glucose 
transport to insulin [4,5]. However, previous in- 
vestigators have observed that catecholamines 
stimulate overall glucose incorporation [6,7] as 
well as the glucose transport rate which was as- 
sessed with non-metabolizable hexoses [&IO]. 
This discrepancy suggests that catecholamines may 
produce differential effects on hexose transport 
and raises the question for the conditions and 
mechanisms underlying the stimulatory and the 
inhibitory action. 
The Bordetella toxin islet-activating protein 
(IAP) has been used as a tool to study the regula- 
tion of adenylate cyclase [ 111. The toxin blocks the 
inhibition of the cyclase presumably by ADP- 
ribosylation of the hypothetical regulatory compo- 
nent Ni [ 12,131. Here IAP has been used to in- 
vestigate whether the action of insulin or of 
isoprenaline on glucose transport are dependent on 
the inhibitory regulation of adenylate cyclase. As 
anticipated, insulin action was not affected by the 
toxin. The stimulatory effect of isoprenaline, 
however, was abolished and reversed to an in- 
hibitory action, suggesting a dual effect of 
isoprenaline on glucose transport. 
2. MATERIALS AND METHODS 
2.1. Materials 
Cristalline porcine insulin was obtained as a gift 
from Hoechst AG (Frankfurt). IAP purified as in 
[14] was obtained from Dr Jakobs, Institute of 
Pharmacology (Heidelberg). Isoprenaline sulfate 
was supplied by Boehringer (Ingelheim). Bovine 
serum albumin (fraction V), adenosine and 
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phloretin were purchased from Serva (Heidelberg). 
Crude bacterial collagenase (type IV) was supplied 
by Worthington Biochemicals (Freehold, NJ). All 
other enzymes were from Boehringer (Mannheim). 
Silicone oil (Cat.no. 6428 R-15) was purchased 
from A.H. Thomas (Philadelphia, PA). Hepes was 
from Sigma (St. Louis, MO). All radiochemicals 
were from Amersham-Buchler (Braunschweig). 
2.2. Isolation of fat cells 
Male albino Wistar rats bred in our institute 
were used throughout (body weight 130-180 g). 
The animals had free access to food and water. 
Isolated fat cells were prepared as in [15] with 
modifications described in [16]. In brief, the 
epididymal adipose tissue of 2-3 rats was digested 
with collagenase (1 mg/ml) in Krebs-Ringer- 
Hepes buffer containing glucose (1 mM) and 4% 
albumin. The cells were filtered through nylon 
mesh, washed, and distributed to the incubation 
vials to yield a concentration of approximately lo5 
cells per ml. All subsequent incubations were car- 
ried out in Krebs-Ringer-Hepes buffer containing 
glucose (1 mM) and 1% albumin. An aliquot of 
the cell suspension was fixed with osmium te- 
troxide [17] and counted in a Fuchs-Rosenthal 
chamber. Total lipid volume was determined by 
centrifugation of an aliquot in a hematocrit tube 
1181. 
2.3. Glucose transport assay 
The uptake rate of 3-0-methylglucose was deter- 
mined as in [ 191, with minor modifications. After 
preincubation with the agents under investigation 
the fat cell suspension was concentrated to yield 
samples of 200 ~1 containing approximately 4 X 
10’ cells. The samples were allowed to equilibrate 
to room temperature (22”C), and were added to 
5 ~1 buffer containing 0.6 ,&i [3H]methylglucose 
(final concentration 0.15 mM). The uptake of the 
glucose analogue was stopped after 3 s by addition 
of 8 ml ice-cold phloretin solution (1 mM). 
Silicone oil was added, and the samples were cen- 
trifuged within 2 min after the termination of the 
transport. Timing of the transport was performed 
with a metronome set at half second intervals. 
Blanks which had been added to the stopping solu- 
tion before addition of radioactivity were included 
in each series, and all data were corrected accor- 
dingly. In control experiments with L-[r4C]glucose 
6 
it was assured that this procedure corrects for all of 
the unspecific ‘transport’ produced by trapped ex- 
tracellular volume. The blanks ranged from 
30-50% of the radioactivity found in the cells 
which was 0.05-0.1% of the total radioactivity. 
The basal uptake after 3 s was lo-20% of the 
equilibrium intracellular water space. 
3. RESULTS AND DISCUSSION 
Isolated fat cells were incubated for 90 min with 
IAP (85 ng/ml) and thereafter subjected to a se- 
cond incubation (20 min) in the presence of in- 
sulin. As is shown in fig.1, IAP failed to 
significantly alter the response to insulin of the 
hexose transport rate. If fat cells were incubated in 
the presence of isoprenaline (1 PM) for 60 min 
prior to the transport assay, the basal hexose 
transport rate was increased by approximately 
Fig.1. Effect of insulin on 3-0-methylglucose transport 
in IAP-treated adipocytes. Means f SE of 6 
experiments. Isolated fat cells (approx. lO’/ml) were 
incubated for 90 min at 37°C in the presence (0) or 
absence (0) of IAP (85 ng/ml). The cell suspension was 
concentrated in order to obtain a sample size sufficient 
for the transport assay, and aliquots were distributed 
into incubation vials containing insulin as indicated. 
After 20 min of incubation at 37°C the samples were 
equilibrated to 22”C, and methylglucose transport was 
determined as described in section 2. Differences to 
control values were not significant throughout. 
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Table 1 
Reversal of the effect of isoprenaline on basal 
adipocytes 
February 1984 
3-0-methylglucose transport in 
3-0-Methylglucose uptake 
(pmol .3 s-r ,pl lipid-‘) 
No addition (11) 
IAP (85 ng/ml) (6) 
Propranolol (10 PM) (5) 
Adenosine deaminase 
Control Isoprenaline P 
0.35 * 0.03 0.52 f 0.05 0.01 
0.33 + 0.06 0.30 f 0.04 n.s. 
0.39 f 0.07 0.42 f 0.04 n.s. 
(2 fig/ml) (8) 0.33 + 0.04 0.40 f 0.04 n.s. 
Isolated fat cells (approx. 10’ cells) were incubated in the presence (or absence) of 
isoprenaline (1 PM) and the indicated agents for 30 min at 37°C. IAP was added 1 h 
prior to the addition of isoprenaline. The cell suspension was concentrated, allowed 
to equilibrate at 22”C, and methylglucose transport was determined as described in 
section 2. Data are means + SE of a number of experiments indicated in parentheses. 
The differences were tested for statistical significance with the U-test of Wilcoxon, 
Mann and Whitney. If p was greater than 0.1, differences were considered to be not 
significant (n.s.) 
40% (table 1, fig.2). This effect was observed in 
the absence of insulin or in the presence of sub- 
maximally stimulating insulin concentrations, but 
disappeared at higher insulin concentrations, and 
seemed to be reversed to an inhibitory effect at 
maximal stimulation of hexose transport by insulin 
(fig.2). 
When fat cells were subjected to a 90-min prein- 
cubation period with IAP (85 ng/ml), the 
stimulatory effect of isoprenaline on glucose 
transport was abolished (table 1). Moreover, in 
cells preincubated with IAP isoprenaline 
significantly inhibited the stimulatory effect of in- 
sulin on glucose transport (fig.3). Further, the 
stimulatory effect of isoprenaline on hexose 
transport was reduced by P-adrenergic blockade 
with propranolol, and by adenosine deaminase 
which removes adenosine spontaneously released 
by isolated fat cells [20]. 
IAP was used here as a tool to investigate 
whether the inhibitory regulation of adenylate 
cyclase might be involved in the stimulation of 
glucose transport by the agents under investiga- 
tion. The results showed that treatment of cells 
with IAP failed to alter the effect of insulin on 
glucose transport. Similarly, recent studies have 
reported that pretreatment of rats with Bordetella 
toxin failed to affect the action of insulin on 
glucose oxidation [21] as well as the antilipolytic 
effect [22,23]. However, the stimulatory effect of 
insulin on phosphatidylinositol turnover was 
enhanced by the treatment [21], indicating that dif- 
O-1 . I . I 1 
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Insulin ( ng/ml) 
Fig.2. Effect of insulin on 3-0-methylglucose transport 
in the presence of isoprenaline. Means + SE of 8 
experiments. Isolated fat cells (approx. lO’/ml) were 
incubated for 30 min at 37°C in the presence (0) and 
absence (0) of isoprenaline (1 PM). The cell suspension 
was concentrated, and insulin was added as indicated. 
After a second incubation period of 20 min the samples 
were equilibrated to 22°C and the transport rate was 
determined. Differences to controls were significant (p < 
0.05) at 0, 0.6 and 2.4 ng/ml insulin. 
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Fig.3. Effect of insulin and isoprenaline on 3-0- 
methylglucose transport in IAP-treated adipocytes. 
Means f SE of 6 experiments. Isolated fat cells were 
incubated for 90 min at 37°C in the presence (0) and 
absence (0) of IAP (85 ng/ml). Isoprenaline (1 pM) 
was added 30 min prior to the end of the incubation. As 
in the experiments hown in fig.1 and 2, the fat cell 
suspension was concentrated and insulin was added as 
indicated. After further 20 min of incubation at 37°C 
the transport assay was performed as described in 
section 2. Differences to controls were significant @ < 
0.05) from 0 to 2.4 ng/ml insulin. 
ferential mechanisms of insulin action might be 
revealed with the aid of IAP. The present results 
are consistent with the conclusion that the effect of 
insulin on glucose transport, like that on glucose 
metabolism and on lipolysis, is not mediated by the 
inhibitory regulation of adenylate cyclase. 
In contrast to the effect of insulin, the 
stimulatory action of isoprenaline was abolished 
when cells were pretreated with IAP. Two explana; 
tions for this effect can be discussed. Firstly, the Ni 
component or an associated GTPase might 
mediate the stimulatory effect of isoprenaline on 
glucose transport. IAP has been reported to ir- 
reversibly block the membrane-bound GTPase 
[ 131, and evidence for a role of GTP in the regula- 
tion of glucose transport in muscle has previously 
been published [24]. However, this explanation of 
the stimulatory effect of isoprenaline is highly 
speculative, since it is based on the assumption that 
isoprenaline xerts a&receptor-mediated action on 
the inhibitory component Ni, in addition to its 
stimulatory effect on adenylate cyclase via N,. 
Secondly, the stimulatory effect of isoprenaline 
might, if not mediated by the inhibitory regulation 
of adenylate cyclase, require a certain inhibition of 
the enzyme. Such an inhibitory effect is produced 
by adenosine which is spontaneously released by 
isolated fat cells during incubation [20]. Pretreat- 
ment of rats with IAP has been reported to block 
the effect of adenosine on adenylate cyclase and 
lipolysis in isolated fat cells [21]. This block of the 
hypothetical Ni component might produce a more 
pronounced response of adenylate cyclase to 
isoprenaline, thereby abolishing the stimulatory ef- 
fect on glucose transport. In favour of the latter 
hypothesis is the finding that adenosine 
deaminase, like IAP, did inhibit the stimulatory ef- 
fect of isoprenaline on glucose transport (table 1). 
Stimulatory [8-lo] as well as inhibitory effects 
[4,5] of isoprenaline on glucose transport have 
been reported by different groups. The present 
results suggest that these seemingly conflicting 
data reflect a dual action of catecholamines which 
might depend on the conditions of incubation ap- 
plied. In our experiments the stimulatory effect of 
isoprenaline prevailed, provided adenosine was 
present in the incubation medium. When cells were 
pretreated with IAP, the inhibitory effect of 
isoprenaline on insulin-stimulated glucose trans- 
port was revealed. Thus the Ni component may be 
a pivotal link in the regulation of adipocyte glucose 
transport. 
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